Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone

Psychopharmacology (Berl)
July 2010
https://pubmed.ncbi.nlm.nih.gov/20386884/

Rationale: Prescription opioid abuse has risen dramatically in the United States as clinicians have increased opioid prescribing for alleviation of both acute and chronic pain. Opioid analgesics with decreased risk for abuse are needed.

The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis

Sleep Medicine Reviews
October 2018
https://www.sciencedirect.com/science/article/abs/pii/S1087079217301521

Mark Shuhkman, MD and Andrey Lev-Weissberg, MD - Psychiatric Disorders (2013 Conference) (LDN, low dose naltrexone)